Outsourced Pharma White Papers

1. The Key To Viral Vector Success 11/11/2024

   Establishing a robust and scalable viral vector process requires a multidisciplinary approach that incorporates expertise in foundational science, analytics, and biomanufacturing.

2. Engineering Reliability In Cell Therapy Manufacturing 2/3/2026

   A cell therapy manufacturing model built on precision planning, digital execution, lifecycle‑ready CMC systems, and transparent collaboration to achieve high reliability and reduce variability across programs.

3. Leak Rate Testing for Freeze Dryers: A Scientific Approach 10/16/2024

   Explore our innovative approach to establishing leak rate acceptance criteria and ensure the integrity of your freeze-drying processes for sterile pharmaceutical production.

4. The Problem With Construction Quality 10/21/2024

   Data center construction quality management is inadequate, with issues traced to human error. A stronger focus on quality control and assurance is needed for success.

5. BioServices: Advanced Solutions For Cell And Gene Therapy Material Management 6/28/2024

   See how supply chain solutions like BioServices can help companies mitigate risk to their overall supply chain while saving valuable capital for the research of their lifesaving therapies.

6. How To Avoid Sticking And Picking In The Tableting Industry 9/23/2024

   Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.

7. A Powerful Non-Destructive Tool For Tablet Characterization 10/6/2025

   Discover how X-ray micro-CT provides vital, non-destructive analysis of a tablet’s internal 3D physical structure. This structural insight is essential for troubleshooting defects and confirming performance.

8. Revolutionizing Lentiviral Vector Manufacturing For In Vivo, Ex Vivo CAR-T Therapies 12/29/2025

   Discover how scalable, cost-effective, and high-quality lentiviral vector manufacturing can accelerate both ex vivo and emerging in vivo CAR-T therapies.

9. Spray Dried Dispersions In Controlled Release Formulations 10/16/2025

   Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.

10. Modern Lentiviral Platforms For Scalable Cell Therapy 1/20/2026

    A new platform approach streamlines lentiviral vector design and manufacturing, boosting yield, lowering costs, and accelerating access to gene‑modified cell therapies worldwide.